Literature DB >> 6967888

Relative susceptibilities of T cell subsets involved in delayed-type hypersensitivity to sheep red blood cells to the in vitro action of 4-hydroperoxycyclophosphamide.

S H Kaufmann, H Hahn, T Diamantstein.   

Abstract

4-Hydroperoxycyclophosphamide, a derivative of cyclophosphamide, in aqueous solution yields 4-hydroxycyclophosphamide, which acts on lymphocytes in vitro. This compound was employed to determine the relative susceptibilities of T cell subsets involved in delayed-type hypersensitivity to sheep red blood cells in vitro. The following ranking order could be established: precursors of suppressor T cells > antigen-activated suppressor T cells > T cells mediating DTH. These data provide direct in vitro evidence that the enhancement of the cellular immune response to sheep red blood cells by cyclophosphamide is due to selective inactivation of suppressor T cells or their precursors, respectively.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967888

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Protective and immunostimulating activity of a low dose of cyclophosphamide in the experimental infection of mice with foot-and-mouth disease virus.

Authors:  E L Portiansky; W M DiGirolamo; R P Laguens
Journal:  Experientia       Date:  1989-01-15

2.  Synergistic effects of locally administered cytostatic drugs and a surfactant on the development of delayed-type hypersensitivity to keyhole limpet haemocyanin in mice.

Authors:  J Limpens; R J Scheper
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  Cell-mediated immunity is enhanced by cytostatic drugs continuously released at the site of antigenic stimulation.

Authors:  A M Claessen; H Valster; H Bril; S Meyer; R J Scheper
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity.

Authors:  R A Kay; A Ferguson
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

5.  Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.

Authors:  M Comabella; K Balashov; S Issazadeh; D Smith; H L Weiner; S J Khoury
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

6.  In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis.

Authors:  Oumaïma Ibrahim-Granet; Grégory Jouvion; Tobias M Hohl; Sabrina Droin-Bergère; François Philippart; Oh Yoen Kim; Minou Adib-Conquy; Reto Schwendener; Jean-Marc Cavaillon; Matthias Brock
Journal:  BMC Microbiol       Date:  2010-04-08       Impact factor: 3.605

7.  In vitro effects of 4-hydroperoxycyclophosphamide on concanavalin A-induced human suppressor T cells.

Authors:  A Klajman; I Drucker; Y Manor; S Ben-Efraim
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

8.  Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide.

Authors:  T H Inge; S K Hoover; J L Frank; T T Kawabata; K P Bethke; H D Bear
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

9.  Pharmacological modulation of suppressor cell activity in mice with disseminated histoplasmosis.

Authors:  G S Deepe; G R Kravitz; W E Bullock
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

10.  The difference between 5-fluorouracil and melphalan in their ability to promote antitumor immune response against MOPC-315 plasmacytoma.

Authors:  S Ben-Efraim; S Shoval; R Ophir
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.